Sepsis is a common risk factor for acute kidney injury (AKI). Bone marrow-derived
mesenchymal stem cells (BMSCs) bear multi-directional differentiation potential. This study …

The use of mesenchymal stem cells (MSCs) has become a new strategy for treating diabetic
kidney disease (DKD). However, the role of placenta derived mesenchymal stem cells (P …

Background Mesenchymal stem cell (MSC) has been widely explored in the past decade as
a cell-based treatment for various diseases. However, poor survival of adaptively transferred …

The present study aimed to explore the repair effect and mechanism of bone marrow
mesenchymal stem cells (BMSCs) transplantation on injured kidneys caused by hexavalent …

The mortality of rhabdomyolysis-induced AKI remains high because no effective therapy
exists. We investigated a new therapeutic method using MSCs. The aim of this study was to …

Background Acute kidney injury (AKI) is an emerging global healthcare issue without
effective therapy yet. Autophagy recycles damaged organelles and helps maintain tissue …

Objective Bone marrow mesenchymal stem cell (BMSC)-derived extracellular vesicles (EVs)
have been demonstrated as a potential therapeutic agent in acute kidney injury (AKI) …

Mesenchymal stem cells (MSCs) have fueled ample translation for treatment of immune-
mediated diseases. Our previous study had demonstrated that MSCs could elicit …

Autophagy, a type II programmed cell death, is essential for cell survival under stress, eg
lung injury, and bone marrow‐derived mesenchymal stem cells (BM‐MSC s) have great …

Acute kidney injury (AKI) remains to be an independent risk factor for mortality and morbidity.
Inflammation is believed to play a major role in the pathophysiology of AKI. Exogenous …